G
Giovanni Rezza
Researcher at Istituto Superiore di Sanità
Publications - 427
Citations - 19053
Giovanni Rezza is an academic researcher from Istituto Superiore di Sanità. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 59, co-authored 381 publications receiving 16576 citations.
Papers
More filters
Journal ArticleDOI
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.
TL;DR: Since then, the number of cases identified in Italy has rapidly increased, mainly in northern Italy, but all regions of the country have reported having patients with COVID-19, and Italy now has the second largest number of CO VID-19 cases and also has a very high case-fatality rate.
Journal ArticleDOI
Infection with chikungunya virus in Italy: an outbreak in a temperate region
Giovanni Rezza,Loredana Nicoletti,R Angelini,Roberto Romi,A C Finarelli,M. Panning,Paolo Cordioli,Claudia Fortuna,S. Boros,Fabio Magurano,G. Silvi,Paola Angelini,Michele Dottori,Maria Grazia Ciufolini,Giancarlo Majori,Antonio Cassone +15 more
TL;DR: In this article, an outbreak of chikungunya virus (CHIKV) was reported in Italy, where the primary source of infection and modes of transmission were identified and an active surveillance system was also implemented.
Journal ArticleDOI
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.
Adriana Ammassari,Rita Murri,Patrizio Pezzotti,Maria Paola Trotta,Laura Ravasio,Patrizio De Longis,Sergio Lo Caputo,Pasquale Narciso,S. Pauluzzi,Giampiero Carosi,Salvatore Nappa,P. Piano,Izzo Cm,Miriam Lichtner,Giovanni Rezza,Antonella d'Arminio Monforte,Giuseppe Ippolito,Mauro Moroni,Albert W. Wu,Andrea Antinori +19 more
TL;DR: In addition to patient characteristics, medication‐related variables, and reasons for nonadherence, patient‐reported symptoms and medication side effects were significantly associated with adherence to HAART.
Journal ArticleDOI
Reduction in Mortality With Availability of Antiretroviral Therapy for Children With Perinatal HIV-1 Infection
M. De Martino,Pier-Angelo Tovo,Maria Balducci,Luisa Galli,Clara Gabiano,Giovanni Rezza,Patrizio Pezzotti +6 more
TL;DR: Survival of perinatally HIV-infected children improved in 1996-1998 as a result of the introduction of combined antiretroviral therapies, suggesting a causal relationship between decreased risk of death and use of combination therapy.
Journal ArticleDOI
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
Cecilia Sgadari,Giovanni Barillari,Elena Toschi,Davide Carlei,Ilaria Bacigalupo,Sara Baccarini,Clelia Palladino,Patrizia Leone,Roberto Bugarini,Laura Malavasi,Aurelio Cafaro,Mario Falchi,Donatella Valdembri,Giovanni Rezza,Federico Bussolino,Paolo Monini,Barbara Ensoli +16 more
TL;DR: Systemic administration of the PIs indinavir or saquinavir to nude mice blocks the development and induces regression of angioproliferative KS-like lesions promoted by primary human KS cells, basic fibroblast growth factor, or bFGF and vascular endothelial growth factor combined.